Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements

Sun, YK; Zhang, W; Bi, XY; Yang, ZQ; Tang, Y; Jiang, LM; Bi, F; Chen, MS; Cheng, SQ; Chi, YHBL; Han, Y; Huang, J; Huang, Z; Ji, Y; Jia, LQ; Jiang, ZC; Jin, J; Jin, ZY; Li, X; Li, ZY; Liang, J; Liu, LX; Liu, YP; Lu, YY; Lu, SC; Meng, QH; Niu, ZX; Pan, HM; Qin, SK; Qu, W; Shao, GL; Shen, F; Song, TQ; Song, Y; Tao, KS; Tian, AP; Wang, JH; Wang, WL; Wang, Z; Wu, LQ; Xia, F; Xing, BC; Xu, JM; Xue, HD; Yan, D; Yang, L; Ying, JM; Yun, JP; Zeng, ZC; Zhang, XW; Zhang, YQ; Zhang, YF; Zhao, JJ; Zhou, JG; Zhu, X; Zou, YH; Dong, JH; Fan, J; Lau, WY; Sun, Y; Yu, JM; Zhao, H; Zhou, AP; Cai, JQ

Zhou, AP (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China.;Zhao, H; Cai, JQ (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Hepatobiliary Surg, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China.

LIVER CANCER, 2022; 11 (3): 192

Abstract

Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and causes many cancer-related deaths worldwide; in China, it is th......

Full Text Link